Jiangxi Synergy Pharmaceutical Co.,Ltd.

The company was founded in 2004 and is mainly engaged in the production of APIs and intermediates. The production capacity and product quality of the main varieties are at the leading level in China. The company's main business is R&D, production and sales of chemical raw materials and pharmaceutical intermediates. The main products are gabapentin APIs, rebapide APIs, aceclofenac APIs, celecoxib APIs, candesartan esters APIs, azisartan APIs, sartan intermediates, dabigatran APIs, tigrello APIs, apixaban APIs, rivaroxaban APIs, vigagliptin APIs, engglizin APIs, venlafaxacin hydrochloride APIs, agomelatine APIs, fibusastat APIs, and mirabelone APIs. Company honors: Jiangsu Intellectual Property Advantage Enterprise, 2015 Advanced Foreign Trade Export Enterprise, A-grade Credit Enterprise, High-tech Enterprise Certificate, etc.